Table 2.
CR on PET/CT | <CR on PET/CT | |
---|---|---|
Cisplatin based | ||
Cisplatin alone | 169 (92%) | 14 (8%) |
Cisplatin + bevacizumab | 35(97%) | 1 (3%) |
Cisplatin + paclitaxel | 3 (100%) | 0 (0%) |
Carboplatin based | ||
Carboplatin + 5-FU | 26 (90%) | 3 (10%) |
Carboplatin + paclitaxel | 8 (80%) | 2 (20%) |
Cetuximab based | ||
Cetuximab alone | 30 (83%) | 6 (17%) |
Cetuximab + paclitaxel | 3 (75%) | 1 (25%) |
Cetuximab + paclitaxel-NAB | 2 (100%) | 0 (0%) |
CR = complete response; <CR = incomplete response; CT = computed tomography; PET = positron emission tomography.